1. Torii S, Ono C, Suzuki R, Morioka Y, Anzai I, Fauzyah Y, Maeda Y, Kamitani W, Fukuhara T and Matsuura Y. A novel reverse genetics system for SARS-CoV-2 by using circular polymerase extension reaction. Cell Rep. 35(3): 109014, 2021
2. Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, Uriu K, Tsuda M, Zahradnik J, Shirakawa K, Suzuki R, Kishimoto M, Kosugi Y, Kobiyama K, Hara T, Toyoda M, Tanaka YL, Butlertanaka EP, Shimizu R, Ito H, Wang L, Oda Y, Orba Y, Sasaki M, Nagata K, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Kuramochi J, Seki M, Fujiki R, Kaneda A, Shimada T, Nakada T, Sakao S, Suzuki T, Ueno T, Takaori-Kondo A, Ishii KJ, Schreiber G, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Saito A, Irie T, Tanaka S, Matsuno K, Fukuhara T (Corresponding author), Ikeda T, Sato K. Virological Characteristics of SARS-CoV-2 BA.2 variant. Cell. In press
3. Torii S, Kim KS, Koseki J, Suzuki R, Iwanami S, Fujita Y, Jeong YD, Matsuura Y, Shimamura T, Iwami S, Fukuhara T (Corresponding author). Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulation. BioRxiv. 2022
4. Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Ikeda T, Irie T, Matsuno K, Tanaka S, Fukuhara T (Corresponding author), Sato K. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 603(7902): 700-705, 2022
5. Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M; Genotype to Phenotype Japan (G2P-Japan) Consortium, Tanaka S, Nakagawa S, Ikeda T, Fukuhara T (Corresponding author), Kawaoka Y, Sato K. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 602(7896): 300-306, 2022
6. Motozono C, Toyoda M, Zahradnik J, Saito A, Nasser H, Tan TS, Ngare I, Kimura I, Uriu K, Kosugi Y, Yue Y, Shimizu R, Ito J, Torii S, Yonekawa A, Shimono N, Nagasaki Y, Minami R, Toya T, Sekiya N, Fukuhara T, Matsuura Y, Schreiber G; Genotype Japan (G2P-Japan) Consortium, Ikeda T, Nakagawa S, Ueno T and Sato K. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 29(7): 1124-36, 2021
7. A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yields. Fujioka Y, Kashiwagi S, Yoshida A, Satoh AO, Fujioka M, Amano M, Yamauchi Y and Ohba Y. bioRxiv 2021.07.30.454063; doi: https://doi.org/10.1101/2021.07.30.454063
8. 北條 慎太郎, 田中 くみ子, 村上 薫, 佐藤 一紀, 村上 正晃:COVID-19における非免疫細胞によるサイトカインストーム発症機構, BIO-EX-press 2022年冬号, 12-17 (2022.1)
9. 佐藤 一紀, 村上 正晃, 今野 哲:臨床的な立場から考察するCOVID-19, BIO-EX-press 2022年冬号, 28-30 (2022.1)
10. 村上 薫, 北條 慎太郎, 田中 くみ子, 村上 正晃:【コロナウイルス感染の免疫学】サイトカインストームとIL-6アンプ, 炎症と免疫 30巻1号, 18-27 (2021.12)